title: U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats.
abstract: This study was designed to investigate if the kappa opioid system regulates the locomotor response to cocaine in the female rat and to determine if the effect is dependent on estradiol treatment. Adult rats were ovariectomized (OVX) and half received an estradiol (OVX-EB) implant. After a week, rats were injected for 5 consecutive days with vehicle or with the kappa opioid receptor (KOPr) agonist U-69593 (0.16, 0.32, and 0.64 mg/kg) 15 min prior to cocaine injection (15 mg/kg). Following a 7-day drug-free period, rats were challenged with cocaine (Day 13). The locomotor response to cocaine was measured on Days 1, 5, and 13. U-69593 (0.32 mg/kg) decreased cocaine-induced locomotor activity in drug-naïve OVX rats and in those that received the OVX-EB implant. These results indicate that the acute effects of U-69593 are independent of estradiol treatment. Repeated exposure to U-69593 (0.32 mg/kg) prior to cocaine decreased the development of behavioral sensitization in OVX-EB-implanted rats. This decrease in cocaine-induced hyperlocomotion persisted after 1 week of cocaine withdrawal. These data indicate that the KOPr system participates in estradiol modulation of cocaine-induced behavioral sensitization in the female rat.
authors.affiliation: Department of Physiology, University of Puerto Rico, School of Medicine, San Juan, Puerto Rico.
authors.forename: Anabel
authors.initials: A
authors.lastname: Puig-Ramos
authors.forename: Gladys S
authors.initials: GS
authors.lastname: Santiago
authors.forename: Annabell C
authors.initials: AC
authors.lastname: Segarra
mesh_terms: D000700:Analgesics / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D044482:Benzeneacetamides / Q000494:pharmacology*; D003042:Cocaine / Q000008:administration & dosage*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004958:Estradiol / Q000008:administration & dosage; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D009043:Motor Activity / Q000187:drug effects*; D010052:Ovariectomy; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
chemical_list: D000700:Analgesics; D044482:Benzeneacetamides; D018765:Dopamine Uptake Inhibitors; D004967:Estrogens; D011759:Pyrrolidines; D004958:Estradiol; D003042:Cocaine; C045444:U 69593